Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Bristow Group
VTOL
$1.34B
| $7.93M | ﹤0.01% |
236,369
-183
| -0.1% | -$5.67K |
|
2152
Arcutis Biotherapeutics
ARQT
$3.36B
| $7.92M | ﹤0.01% |
851,324
+100,600
| +13% | +$910K |
|
2153
Krispy Kreme
DNUT
$548M
| $7.85M | ﹤0.01% |
729,970
-11,788
| -2% | -$146K |
|
2154
ImmunityBio
IBRX
$7.51B
| $7.81M | ﹤0.01% |
1,236,316
+65,104
| +6% | +$429K |
|
2155
Hyster-Yale Materials Handling
HY
$599M
| $7.73M | ﹤0.01% |
110,863
+13,393
| +14% | +$914K |
|
2156
Arcus Biosciences
RCUS
$3.55B
| $7.73M | ﹤0.01% |
507,443
+14,167
| +3% | +$229K |
|
2157
Monarch Casino & Resort
MCRI
$2.2B
| $7.68M | ﹤0.01% |
112,738
+2,329
| +2% | +$159K |
|
|
OSG
2158
Octave Specialty Group
OSG
$243M
| $7.68M | ﹤0.01% |
599,068
-67,004
| -10% | -$1.02M |
|
|
EHAB
2159
DELISTED
Enhabit
EHAB
| $7.67M | ﹤0.01% |
859,976
-190,375
| -18% | -$1.82M |
|
|
CYBR
2160
DELISTED
CyberArk
CYBR
| $7.67M | ﹤0.01% |
28,043
+1,913
| +7% | +$470K |
|
|
CGAU
2161
Centerra Gold
CGAU
$3.36B
| $7.66M | ﹤0.01% |
+1,139,788
| New | +$7.48M |
|
2162
Genesco
GCO
$425M
| $7.66M | ﹤0.01% |
296,111
-63,497
| -18% | -$1.66M |
|
2163
Amneal Pharmaceuticals
AMRX
$5.85B
| $7.63M | ﹤0.01% |
1,202,020
-28,314
| -2% | -$180K |
|
2164
Sphere Entertainment
SPHR
$5.14B
| $7.63M | ﹤0.01% |
217,605
+5,495
| +3% | +$214K |
|
2165
Mercantile Bank Corp
MBWM
$1.04B
| $7.62M | ﹤0.01% |
187,911
-10,505
| -5% | -$393K |
|
|
SFIX
2166
Stitch Fix
SFIX
$536M
| $7.61M | ﹤0.01% |
1,833,258
-308,888
| -14% | -$837K |
|
|
SNBR
2167
DELISTED
Sleep Number
SNBR
| $7.59M | ﹤0.01% |
793,154
-182,581
| -19% | -$2.5M |
|
2168
Varex Imaging
VREX
$472M
| $7.57M | ﹤0.01% |
514,209
-26,812
| -5% | -$429K |
|
2169
Green Dot
GDOT
$743M
| $7.56M | ﹤0.01% |
800,273
-51,305
| -6% | -$477K |
|
2170
QuinStreet
QNST
$890M
| $7.55M | ﹤0.01% |
455,302
+9,974
| +2% | +$173K |
|
2171
CareDx
CDNA
$2.26B
| $7.55M | ﹤0.01% |
485,933
-82,567
| -15% | -$998K |
|
|
HAPN
2172
Happen Inc
HAPN
$2.21B
| $7.54M | ﹤0.01% |
891,263
+23,059
| +3% | +$197K |
|
2173
Baytex Energy
BTE
$3.25B
| $7.53M | ﹤0.01% |
+2,173,486
| New | +$7.78M |
|
2174
Mercer International
MERC
$42.3M
| $7.51M | ﹤0.01% |
879,425
-127,833
| -13% | -$1.23M |
|
2175
IAMGOLD
IAG
$8.2B
| $7.49M | ﹤0.01% |
+1,994,763
| New | +$7.6M |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.